vs
Side-by-side financial comparison of iQSTEL Inc (IQST) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $76.2M, roughly 1.1× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -3.2%, a 10.6% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -14.9%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-1.2M). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs 22.7%).
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
IQST vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $84.2M | $76.2M |
| Net Profit | $-2.7M | $5.6M |
| Gross Margin | 3.5% | 57.9% |
| Operating Margin | -2.9% | 11.0% |
| Net Margin | -3.2% | 7.4% |
| Revenue YoY | -14.9% | 25.5% |
| Net Profit YoY | -44.5% | 30.7% |
| EPS (diluted) | $-0.92 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $84.2M | $76.2M | ||
| Q3 25 | $102.9M | $71.9M | ||
| Q2 25 | $72.2M | $63.1M | ||
| Q1 25 | $57.6M | $59.1M | ||
| Q4 24 | $98.9M | $60.7M | ||
| Q3 24 | $54.2M | $58.0M | ||
| Q2 24 | $78.6M | $55.0M | ||
| Q1 24 | $51.4M | $50.6M |
| Q4 25 | $-2.7M | $5.6M | ||
| Q3 25 | $-2.3M | $3.5M | ||
| Q2 25 | $-2.3M | $3.2M | ||
| Q1 25 | $-1.1M | $2.6M | ||
| Q4 24 | $-1.9M | $4.3M | ||
| Q3 24 | $-773.0K | $3.9M | ||
| Q2 24 | $-2.0M | $1.5M | ||
| Q1 24 | $-580.2K | $1.6M |
| Q4 25 | 3.5% | 57.9% | ||
| Q3 25 | 2.7% | 57.5% | ||
| Q2 25 | 2.6% | 58.3% | ||
| Q1 25 | 3.4% | 56.3% | ||
| Q4 24 | 2.7% | 59.5% | ||
| Q3 24 | 3.7% | 59.3% | ||
| Q2 24 | 2.8% | 59.8% | ||
| Q1 24 | 2.7% | 58.9% |
| Q4 25 | -2.9% | 11.0% | ||
| Q3 25 | -0.5% | 7.8% | ||
| Q2 25 | -0.9% | 8.1% | ||
| Q1 25 | -1.0% | 6.5% | ||
| Q4 24 | -0.3% | 10.6% | ||
| Q3 24 | -0.1% | 9.7% | ||
| Q2 24 | -0.4% | 6.6% | ||
| Q1 24 | -0.4% | 4.4% |
| Q4 25 | -3.2% | 7.4% | ||
| Q3 25 | -2.3% | 4.9% | ||
| Q2 25 | -3.3% | 5.0% | ||
| Q1 25 | -2.0% | 4.4% | ||
| Q4 24 | -1.9% | 7.1% | ||
| Q3 24 | -1.4% | 6.7% | ||
| Q2 24 | -2.5% | 2.7% | ||
| Q1 24 | -1.1% | 3.2% |
| Q4 25 | $-0.92 | $0.14 | ||
| Q3 25 | $-0.68 | $0.09 | ||
| Q2 25 | $-0.82 | $0.08 | ||
| Q1 25 | $-0.44 | $0.06 | ||
| Q4 24 | $-1.19 | $0.10 | ||
| Q3 24 | $-0.40 | $0.10 | ||
| Q2 24 | $-0.90 | $0.04 | ||
| Q1 24 | $-0.37 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $13.5M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $16.3M | $141.5M |
| Total Assets | $51.1M | $199.2M |
| Debt / EquityLower = less leverage | 0.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $13.5M | ||
| Q3 25 | $2.3M | $11.1M | ||
| Q2 25 | $2.0M | $20.0M | ||
| Q1 25 | $1.1M | $10.2M | ||
| Q4 24 | $2.5M | $17.5M | ||
| Q3 24 | $2.1M | $11.3M | ||
| Q2 24 | $797.2K | $8.8M | ||
| Q1 24 | $2.7M | $7.3M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $3.5M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $2.5M | — | ||
| Q1 24 | $194.0K | — |
| Q4 25 | $16.3M | $141.5M | ||
| Q3 25 | $17.9M | $133.6M | ||
| Q2 25 | $14.3M | $139.7M | ||
| Q1 25 | $11.6M | $134.8M | ||
| Q4 24 | $11.9M | $131.4M | ||
| Q3 24 | $8.1M | $125.0M | ||
| Q2 24 | $7.6M | $119.4M | ||
| Q1 24 | $8.4M | $116.3M |
| Q4 25 | $51.1M | $199.2M | ||
| Q3 25 | $46.9M | $202.4M | ||
| Q2 25 | $51.4M | $184.6M | ||
| Q1 25 | $42.0M | $178.1M | ||
| Q4 24 | $79.0M | $177.1M | ||
| Q3 24 | $32.4M | $169.5M | ||
| Q2 24 | $30.0M | $163.9M | ||
| Q1 24 | $22.1M | $154.9M |
| Q4 25 | 0.25× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $18.4M |
| Free Cash FlowOCF − Capex | $-1.2M | $9.7M |
| FCF MarginFCF / Revenue | -1.5% | 12.7% |
| Capex IntensityCapex / Revenue | 0.0% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $-4.0M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $18.4M | ||
| Q3 25 | $-953.0K | $18.4M | ||
| Q2 25 | $257.7K | $12.3M | ||
| Q1 25 | $-1.9M | $2.9M | ||
| Q4 24 | $-403.7K | $15.0M | ||
| Q3 24 | $625.0K | $12.7M | ||
| Q2 24 | $-2.6M | $10.2M | ||
| Q1 24 | $-536.9K | $1.2M |
| Q4 25 | $-1.2M | $9.7M | ||
| Q3 25 | $-969.2K | $10.7M | ||
| Q2 25 | $211.7K | $4.1M | ||
| Q1 25 | $-2.0M | $-12.6M | ||
| Q4 24 | $-421.3K | $3.2M | ||
| Q3 24 | $594.5K | $1.7M | ||
| Q2 24 | $-2.6M | $1.2M | ||
| Q1 24 | $-608.5K | $-4.8M |
| Q4 25 | -1.5% | 12.7% | ||
| Q3 25 | -0.9% | 14.9% | ||
| Q2 25 | 0.3% | 6.5% | ||
| Q1 25 | -3.4% | -21.4% | ||
| Q4 24 | -0.4% | 5.2% | ||
| Q3 24 | 1.1% | 3.0% | ||
| Q2 24 | -3.4% | 2.3% | ||
| Q1 24 | -1.2% | -9.5% |
| Q4 25 | 0.0% | 11.5% | ||
| Q3 25 | 0.0% | 10.6% | ||
| Q2 25 | 0.1% | 12.9% | ||
| Q1 25 | 0.1% | 26.2% | ||
| Q4 24 | 0.0% | 19.5% | ||
| Q3 24 | 0.1% | 19.0% | ||
| Q2 24 | 0.0% | 16.3% | ||
| Q1 24 | 0.1% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
VMD
Segment breakdown not available.
